CAS 879562-26-2
:(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-methylethenyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazol-5-carboxylat
Formel:C29H28N6O5
InChl:InChI=1S/C29H28N6O5/c1-5-8-24-30-25(17(2)3)26(28(36)38-16-23-18(4)39-29(37)40-23)35(24)15-19-11-13-20(14-12-19)21-9-6-7-10-22(21)27-31-33-34-32-27/h6-7,9-14H,2,5,8,15-16H2,1,3-4H3,(H,31,32,33,34)
InChI Key:InChIKey=PSFJJUXSEHXDFN-UHFFFAOYSA-N
SMILES:C(N1C(C(OCC2=C(C)OC(=O)O2)=O)=C(C(C)=C)N=C1CCC)C3=CC=C(C=C3)C4=C(C=CC=C4)C=5NN=NN5
Synonyme:- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2′-(2H-tetrazol-5-yl)-[1,1′-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
- (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-methylethenyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylate
- 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- 1H-Imidazole-5-carboxylic acid, 4-(1-methylethenyl)-2-propyl-1-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl ester
- Olmesartan medoxomil impurity I
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
11 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Isopropenyl Olmesartan Medoxomil
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormel:C29H28N6O5Farbe und Form:White SolidMolekulargewicht:540.21212(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
CAS:(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylateFormel:C29H28N6O5Reinheit:98%Molekulargewicht:540.58Olmesartan medoxomil impurity C
CAS:Impurity C of Olmesartan medoxomil is a selective AT1 inhibitor with an IC50 of 66.2 μM.Formel:C29H28N6O5Farbe und Form:SolidMolekulargewicht:540.57Olmesartan Medoxomil EP Impurity C
CAS:Formel:C29H28N6O5Farbe und Form:White To Off-White SolidMolekulargewicht:540.58(5-METHYL-2-OXO-1,3-DIOXOL-4-YL)METHYL 1-((2'-(2H-TETRAZOL-5-YL)-[1,1'-BIPHENYL]-4-YL)METHYL)-4-(PROP-1-EN-2-YL)-2-PROPYL-1H-IMIDAZOLE-5-CARBOXYLATE
CAS:Formel:C29H28N6O5Reinheit:97%Farbe und Form:SolidMolekulargewicht:540.5698(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(1-Methylethenyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylate
CAS:Formel:C29H28N6O5Farbe und Form:NeatMolekulargewicht:540.57Dehydro Olmesartan Medoxomil
CAS:Kontrolliertes ProduktImpurity Olmesartan EP Impurity C/ Olmesartan Impurity RNH 6373
Applications Dehydro Olmesartan Medoxomil (Olmesartan EP Impurity C) is an intermediate used in the process for purifying Olmesartan Medoxomil.
References Yanagisawa, H., et al.: J. Med. Chem., 39, 323 (1996),Formel:C29H28N6O5Farbe und Form:NeatMolekulargewicht:540.57(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylate
CAS:(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(prop-1-en-2-yl)-2-propyl-1H-imidazole-5-carboxylateFormel:C29H28N6O5Reinheit:98%Molekulargewicht:540.57Olmesartan EP Impurity C
CAS:Olmesartan medoxomil is a prodrug that is metabolized to the active form, olmesartan, in the liver. The esters of olmesartan medoxomil are metabolized by hydrolysis and by esterases. The most common side effects of olmesartan medoxomil are headache, dizziness, fatigue, nausea and diarrhea. Olmesartan medoxomil is used for the treatment of high blood pressure in adults. This drug also has anti-inflammatory properties due to its inhibition of prostaglandin synthesis.
Formel:C29H28N6O5Reinheit:Min. 95%Farbe und Form:White Off-White PowderMolekulargewicht:540.57 g/mol










